China and Saudi lead in use of AI in Healthcare
Royal Philips, a global leader in health technology, today released a new report which finds that Singapore’s healthcare professionals are not yet leveraging Artificial Intelligence (AI) to its full potential for treatment and diagnosis.
Future Health Index (FHI) 2019 reports it is emerging countries that are leading the way for AI use in diagnosis globally with nearly half (45%) of China’s healthcare professionals, and more than a third in Saudi Arabia (34%), using AI technology to improve the accuracy of their diagnoses.
Elsewhere in the region, India is not far behind Singapore in its healthcare professionals’ useof AI for improving the accuracy of diagnosis (26%), but Australian healthcare professionals record the lowest use amongst the 15 countries in the study at just 8%.
The report also hints that apprehension amongst Singapore’s healthcare professionals may be One of the barriers to wider adoption, with one in five (20%) admitting that they fear their long-term job security is threatened by new advancements in healthcare technology, such as AI and telehealth.
“By primarily using Artificial Intelligence for administrative tasks, like scheduling appointments, Singapore’s healthcare professionals risk missing out on the enormous benefits it can bring to patient outcomes,” said Caroline Clarke, CEO, Philips ASEAN Pacific.